Taselisib
CAS: 1282512-48-4
Ref. TM-T1999
2mg | 45.00 € | ||
5mg | 66.00 € | ||
10mg | 90.00 € | ||
25mg | 154.00 € | ||
50mg | 194.00 € | ||
100mg | 343.00 € | ||
200mg | 513.00 € | ||
500mg | 827.00 € | ||
1mL*10mM (DMSO) | 67.00 € |
Product Information
- RG-7604
- GDC-0032
- 1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
- GDC 0032
- RG 7604
- 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-1H-pyrazole-1-acetamide
Taselisib (GDC-0032) is an oral PI3K alpha inhibitor with potential cancer-treating properties.
Chemical properties
Technical inquiry about: TM-T1999 Taselisib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.